Clinical Trial Update: Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma

View source ↗

Summary

A clinical trial evaluating whether blocking tumor necrosis factor (TNF) can enhance immune checkpoint inhibitor–driven immune activation in melanoma. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Melanoma, Immune Defect | Status: RECRUITING